CompuGroup Medical SE / Key word(s): Share Buyback
Management Board of CompuGroup Medical SE decides to terminate share buyback program

31-Oct-2019 / 09:16 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Key word(s): Share Buyback, Termination

Management Board of CompuGroup Medical SE decides to terminate share buyback program

Koblenz, October 31, 2019 - The Management Board of CompuGroup Medical SE, Koblenz, ISIN DE0005437305, has decided today to terminate the share buyback program as announced on September 17, 2019 with immediate effect.

The total number of shares repurchased by CompuGroup Medical SE under the share buyback program since September 18, 2019 amounts to 415,599. The total number of treasury shares currently held by CompuGroup Medical SE amounts to 4,806,709. This corresponds to 9.03% of all shares in CompuGroup Medical SE.
For further information, please refer to:

CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany

Contact person:


Claudia Thomé Head of Investor Relations CompuGroup Medical SE email: claudia.thome@cgm.com phone +49 261 8000 7030 phone +49 261 8000 6200

31-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Attachments

  • Original document
  • Permalink

Disclaimer

CompuGroup Medical SE published this content on 31 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2019 08:41:01 UTC